Moreover, the Wnt signaling pathway, which is frequently dysregulated in various cancers, can modulate NRF2 expression, identifying Wnt–NRF2 crosstalk as a promising target for ferroptosis-centric therapies in cervical cancer (51). Here, NFE2L2 is linked to cervical carcinoma.